A dual biomarker detection platform for quantitating circulating tumor DNA (ctDNA)

Circulating tumor DNA (ctDNA), which includes DNA mutations, epigenetic alterations and other forms of tumor-specific abnormalities, is a promising “real-time” biomarker for noninvasive cancer assessment. Tumor DNA is of great value in the process of cancer treatment, including diagnostic and progno...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Chunyan, Guo, Zhenzhong, Cao, Yiping, Zhang, Weiying, Chen, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743835/
https://www.ncbi.nlm.nih.gov/pubmed/29291160
http://dx.doi.org/10.7150/ntno.22419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743835/
https://www.ncbi.nlm.nih.gov/pubmed/29291160
http://dx.doi.org/10.7150/ntno.22419

Ejemplares similares